Conduit Pharmaceuticals Inc (CDT) Stock Price, Quote & News

Company Profile

CDT Equity Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It has stra...

Industry: Biotechnology

Sector: Healthcare

Phone: 646 491 9132

Website: www.conduitpharma.com

Address:

4581 Tamiami Trail North, Suite 200, Naples, United States

ka1954 Apr. 24 at 9:06 PM

$CDT never saw a piece of crap like this ever

0 · Reply

Bullish_Bearish88 Apr. 24 at 6:15 PM

$CDT The fact that SEC is letting this to continue trading is telling how crooked they are . Shell company that sales shares nothing more . See you at bankruptcy 😭

0 · Reply

Sam201 Apr. 24 at 3:38 PM

$CDT some more! Holding 8k shares now. This should easily cross 15 if they want to offer all 5.3 million shares to raise $75 millions. With float of 660k - quite possible!!

1 · Reply

Reminderz Apr. 23 at 8:09 PM

$CDT $ADV $RENX $ONCO way

0 · Reply

Sam201 Apr. 23 at 7:55 PM

$CDT n more! Borrowing cost over 350%!!!

0 · Reply

Sam201 Apr. 22 at 4:40 PM

$CDT n more!

0 · Reply

Sam201 Apr. 22 at 4:40 PM

$CDT this will repeat $GNLN . Tiny float!

1 · Reply

Nevilhch Apr. 22 at 1:05 PM

$CDT These days they'll come up with any old nonsense to dilute those 5 million shares. This is an easy short sell at 0.1 againnnnnn

0 · Reply

Bullish_Bearish88 Apr. 22 at 11:10 AM

$CDT when bankruptcy? 😂 short back to 0.5cent

3 · Reply

Ga2025 Apr. 21 at 4:45 PM

$MLGO $CDT $HOLO aren't you lucky...just those you have shorted..

1 · Reply

CDT Expands Multi-Pathway Value Creation Strategy Across Pharma, IP and AI-Driven Discovery

Apr 13, 2026, 12:38 PM EDT - 12 days ago

What's Going On With CDT Equity Shares On Monday?

Apr 7, 2026, 8:30 AM EDT - 18 days ago

CDT Notes Sarborg Publication of PRISM Framework Expanding AI

Mar 26, 2026, 8:30 AM EDT - 4 weeks ago

CDT Equity Expands Tapinarof Intellectual Property Portfolio with Two New Patent Filings

Mar 25, 2026, 8:00 AM EDT - 4 weeks ago

CDT Equity Inc. Announces Reverse Stock Split

Mar 23, 2026, 8:30 AM EDT - 4 weeks ago

CDT Identifies Rare Disease Opportunities Through Sarborg Signature Analysis, Advancing Out-Licensing Strategy

Mar 18, 2026, 8:30 AM EDT - 5 weeks ago

CDT Equity Stockholders Approve All Proposals at Special Meeting, Positioning the Company for Next Phase of Growth

Mar 12, 2026, 8:30 AM EDT - 6 weeks ago

CDT Notes Sarborg Expansion into Rare Disease Signature Intelligence

Mar 5, 2026, 8:30 AM EST - 7 weeks ago

CDT Equity Notes Sarborg Filing of U.S. Provisional Patent Application for AI Signature Agent

Mar 4, 2026, 8:30 AM EST - 7 weeks ago

CDT Positions for Transformational Growth

Feb 24, 2026, 8:30 AM EST - 2 months ago

CDT Equity Notes Sarborg Expansion into Bacteria and Agrochemicals

Feb 20, 2026, 8:30 AM EST - 2 months ago

CDT Acquires Strategic Stake in Sarborg to Transform its AI-Driven Asset Strategy

Jan 2, 2026, 8:30 AM EST - 4 months ago

CDT Engages NJS Foresight Bio-Advisory to Support Solid-Form Out-Licensing Strategy

Oct 17, 2025, 8:30 AM EDT - 6 months ago

CDT Equity Increases Bitcoin Holding

Sep 17, 2025, 8:30 AM EDT - 7 months ago

CDT Executes Cryptocurrency Treasury Reserve Strategy

Aug 26, 2025, 8:30 AM EDT - 8 months ago

CDT Equity Identifies New Biological Target Validating AI-Driven Repurposing Strategy

Aug 5, 2025, 8:30 AM EDT - 9 months ago

Conduit to Change Name to CDT Equity Inc.

Jul 8, 2025, 8:30 AM EDT - 10 months ago

Conduit Engages Consultant to Explore Cryptocurrency Reserve Strategy

Jul 7, 2025, 8:30 AM EDT - 10 months ago

Conduit Pharmaceuticals Files New Patents Following AI-Driven Combination Discoveries

Jun 4, 2025, 8:30 AM EDT - 11 months ago

Conduit Pharmaceuticals Enters Joint Development Agreement with Manoira to Advance AZD1656 and AZD5658 in Animal Health

May 22, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Inc. Listing on Nasdaq Capital Market

May 21, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Inc. Regains Nasdaq Compliance

May 16, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Inc. Announces Reverse Stock Split

May 9, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Receives Further Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

May 8, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Files Composition of Matter Patent for AZD5904 Creating Robust IP Foundation for Pipeline Asset

Apr 16, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Announces Leadership Changes

Apr 11, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Announces Novel Cocrystal Patent Filing For VTAMA® (tapinarof) with Enhanced Therapeutic and Market Extension Prospects

Mar 31, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Receives U.S. Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

Mar 19, 2025, 8:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Provides Research and Development Update on Progress for Pipeline Assets AZD1656, AZD5658, and AZD5904

Mar 6, 2025, 9:35 AM EST - 1 year ago

Conduit Pharmaceuticals Provides Update on Nasdaq Stock Market Hearing Panel

Feb 20, 2025, 8:00 AM EST - 1 year ago

Conduit Progresses Phase II of its AI Initiative with Sarborg

Feb 13, 2025, 8:00 AM EST - 1 year ago

Conduit Pharmaceuticals Partners with Charles River in Clinically Relevant Systemic Lupus Erythematosus Model

Feb 11, 2025, 9:00 AM EST - 1 year ago

Conduit Pharmaceuticals Announces Debt Repayment and Partial Conversion of Senior Secured Note

Feb 7, 2025, 8:00 AM EST - 1 year ago

Conduit Pharmaceuticals Transitions to Phase II of Sarborg Collaboration to Support AI-Driven Drug Development

Jan 28, 2025, 5:30 AM EST - 1 year ago

Conduit Pharmaceuticals Completes Strategic Review with Sarborg to Map Revolutionizing Drug Development with Artificial Intelligence

Dec 12, 2024, 7:30 AM EST - 1 year ago

Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics

Nov 21, 2024, 7:30 AM EST - 1 year ago

Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders

Nov 19, 2024, 4:30 PM EST - 1 year ago

Conduit Pharmaceuticals Announces Appointment of Simon Fry to Board of Directors

Nov 4, 2024, 7:30 AM EST - 1 year ago

Conduit Pharmaceuticals Announces New Addition to its Autoimmune Pipeline

Nov 1, 2024, 4:45 PM EDT - 1 year ago

Conduit Pharmaceuticals Announces Debt Restructuring and Additional Notes

Aug 12, 2024, 7:00 AM EDT - 1 year ago

Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune Disorders

Aug 8, 2024, 6:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets to Advance Potential First-in-Class Treatments

May 22, 2024, 7:00 AM EDT - 2 years ago

AstraZeneca furthers ambition to transform outcomes in early lung cancer and redefine metastatic breast cancer treatment at ASCO 2024

AZN

May 21, 2024, 8:00 AM EDT - 2 years ago

Daiichi Sankyo Highlights Progress in Creating New Standards of Care for Patients Across Multiple Cancers at ASCO

Mar 19, 2024, 7:00 AM EDT - 2 years ago

Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer

Mar 11, 2024, 7:00 AM EDT - 2 years ago

Conduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe's Leading Life Sciences Hub

Jan 31, 2024, 8:30 AM EST - 2 years ago

Conduit Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Nov 2, 2023, 8:30 AM EDT - 2 years ago

Conduit Pharmaceuticals to Participate in the 14th Annual Jefferies London Healthcare Conference

Oct 11, 2023, 8:30 AM EDT - 2 years ago

Conduit Pharmaceuticals Partners with ClinConnect on Cocrystal Development Program for AZD1656

Oct 11, 2023, 8:30 AM EDT - 2 years ago

ClinConnect Partners with Conduit Pharmaceuticals on Cocrystal Development Program for AZD1656

ka1954 Apr. 24 at 9:06 PM

$CDT never saw a piece of crap like this ever

0 · Reply

Bullish_Bearish88 Apr. 24 at 6:15 PM

$CDT The fact that SEC is letting this to continue trading is telling how crooked they are . Shell company that sales shares nothing more . See you at bankruptcy 😭

0 · Reply

Sam201 Apr. 24 at 3:38 PM

$CDT some more! Holding 8k shares now. This should easily cross 15 if they want to offer all 5.3 million shares to raise $75 millions. With float of 660k - quite possible!!

1 · Reply

Reminderz Apr. 23 at 8:09 PM

$CDT $ADV $RENX $ONCO way

0 · Reply

Sam201 Apr. 23 at 7:55 PM

$CDT n more! Borrowing cost over 350%!!!

0 · Reply

Sam201 Apr. 22 at 4:40 PM

$CDT n more!

0 · Reply

Sam201 Apr. 22 at 4:40 PM

$CDT this will repeat $GNLN . Tiny float!

1 · Reply

Nevilhch Apr. 22 at 1:05 PM

$CDT These days they'll come up with any old nonsense to dilute those 5 million shares. This is an easy short sell at 0.1 againnnnnn

0 · Reply

Bullish_Bearish88 Apr. 22 at 11:10 AM

$CDT when bankruptcy? 😂 short back to 0.5cent

3 · Reply

Ga2025 Apr. 21 at 4:45 PM

$MLGO $CDT $HOLO aren't you lucky...just those you have shorted..

1 · Reply

Nevilhch Apr. 21 at 3:24 PM

$MLGO $CDT $HOLO This is going to zero soon. I just received a response from eToro's technical support, and they don't plan to reopen trading on this tickers ever again because there are likely to be regulatory issues. In the same email, they recommend closing and accepting losses, given that a significant dilution of shares is very likely before July🤨🤨🤨

0 · Reply

Sam201 Apr. 17 at 4:31 PM

$CDT getting back sold shares- bit by bit

0 · Reply

Natalie777 Apr. 17 at 3:26 PM

$CDT alerted my people at $3.23 last night...

1 · Reply

SuminskiStonks Apr. 17 at 12:16 PM

$RUBI Can have one of the biggest short squeezes we’ve ever seen. Just needs a lot of buys from bulls to burn the shorts. Low float and extremely undervalued, it’s a matter of time 📈 $AKAN $AMP $CDT $RDGT

0 · Reply

Bullish_Bearish88 Apr. 17 at 11:53 AM

$CDT hey no one is buying this trash , let’s try put word AI and see if it would sucker in some more retail 🤡 🩸🔪

0 · Reply